Honeysuckle-Derived Exosome-Like Nanovesicles Alleviate Cisplatin-Induced Acute Kidney Injury by Anti-Inflammation and Mitochondrial Function Protection
Original Article|Updated:2026-02-14
|
Honeysuckle-Derived Exosome-Like Nanovesicles Alleviate Cisplatin-Induced Acute Kidney Injury by Anti-Inflammation and Mitochondrial Function Protection
Honeysuckle-Derived Exosome-Like Nanovesicles Alleviate Cisplatin-Induced Acute Kidney Injury by Anti-Inflammation and Mitochondrial Function Protection
Chinese Journal of Integrative Medicine2026年32卷第1期 页码:34-42
Affiliations:
1.College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou (310014), China
2.Emergency and Critical Care Center, Intensive Care Unit, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou (310014), China
3.Clinical Research Institute, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou (310014), China
Author bio:
Prof. YANG Xiang-hong, E-mail: jyy623@163.com
Funds:
Provincial Key R&D Program Project of Zhejiang Provincial Science and Technology Department(2019C03024)
GONG Wan-cheng, LI Jing-xuan, HU Xiao-juan, 等. Honeysuckle-Derived Exosome-Like Nanovesicles Alleviate Cisplatin-Induced Acute Kidney Injury by Anti-Inflammation and Mitochondrial Function Protection[J]. Chinese Journal of Integrative Medicine, 2026,32(1):34-42.
GONG Wan-cheng, LI Jing-xuan, HU Xiao-juan, et al. Honeysuckle-Derived Exosome-Like Nanovesicles Alleviate Cisplatin-Induced Acute Kidney Injury by Anti-Inflammation and Mitochondrial Function Protection[J]. Chinese Journal of Integrative Medicine, 2026, 32(1): 34-42.
GONG Wan-cheng, LI Jing-xuan, HU Xiao-juan, 等. Honeysuckle-Derived Exosome-Like Nanovesicles Alleviate Cisplatin-Induced Acute Kidney Injury by Anti-Inflammation and Mitochondrial Function Protection[J]. Chinese Journal of Integrative Medicine, 2026,32(1):34-42. DOI: 10.1007/s11655-025-4026-3.
GONG Wan-cheng, LI Jing-xuan, HU Xiao-juan, et al. Honeysuckle-Derived Exosome-Like Nanovesicles Alleviate Cisplatin-Induced Acute Kidney Injury by Anti-Inflammation and Mitochondrial Function Protection[J]. Chinese Journal of Integrative Medicine, 2026, 32(1): 34-42. DOI: 10.1007/s11655-025-4026-3.
Honeysuckle-Derived Exosome-Like Nanovesicles Alleviate Cisplatin-Induced Acute Kidney Injury by Anti-Inflammation and Mitochondrial Function Protection
摘要
Abstract
Objective:
2
To explore the potential of honeysuckle-derived exosome-like nanovesicles (HELNVs) for preventing cisplatin-induced acute kidney injury (AKI).
Methods:
2
The renoprotective efficacy of HELNVs against cisplatin-induced AKI was assessed in human kidney cell-2 (HK-2) cells exposed to 100 μmol/L cisplatin for 24 h
followed by HELNVs (50–200 μg/mL) for another 24 h; the optimal therapeutic concentration was determined as 100 μg/mL. At this concentration
oxygen species (ROS) levels were measured by flow cytometry. Male C57BL/6 mice received a single intraperitoneal injection of cisplatin (30 mg/kg) to establish an AKI model and were then computer-randomized into 3 groups (
n
=6 per group): control group
daily intraperitoneal administration of normal saline (0.9% NaCl); the cisplatin-injured group
same NaCl regimen; the HELNVs treatment group
daily intraperitoneal administration of HELNVs (30 mg/kg) for 5 consecutive days
with euthanasia on day 6. Renal accumulation of HELNVs was tracked by small-animal multispectral imaging (peak uptake at 8–10 h). Functional assessment included serum creatinine and blood urea nitrogen (BUN) quantified with an automated biochemical analyzer. Molecular analyses included enzyme-linked immunosorbent assay (ELISA) quantification of interleukin (IL)-1β
IL-6
IL-10
and tumor necrosis factor-α (TNF-α).
Results:
2
HELNVs significantly reduced ROS
inflammatory responses
and apoptosis in cisplatin-treated HK-2 cells (
P
<
0.01). In cisplatin-induced AKI mice
HELNVs were efficiently absorbed by kidney cells
effectively prevented oxidative damage and mitochondrial dysfunction (
P
<
0.01). Following treatment with 30 mg/kg HELNVs
serum creatinine and BUN levels were markedly reduced (
P
<
0.01). ELISA results showed decreased levels of IL-1β
IL-6
and TNF-α
along with up-regulated IL-10 (
P
<
0.01).
Conclusion:
2
HELNVs may serve as a promising therapeutic approach for ameliorating cisplatin-induced AKI
offering a potential novel treatment option for managing this condition in clinical settings.
关键词
Keywords
references
The trial reading is over, you can activate your VIP account to continue reading.